Protective effects of baicalin on LPS-induced injury in intestinal epithelial cells and intercellular tight junctions. 2015

Jian Chen, and Ren Zhang, and Jian Wang, and Peng Yu, and Quan Liu, and Dan Zeng, and Houpan Song, and Zaoyuan Kuang
School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.

OBJECTIVE To investigate the protective effects and mechanisms of baicalin on lipopolysaccharide (LPS)-induced injury in intestinal epithelial cells and intercellular tight junctions. METHODS IEC-6 cells were stimulated with LPS (1.0 μg/mL), with or without baicalin, for 24 h. The levels of the inflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-α were determined using ELISA. Quantitative real-time PCR was used for determining the mRNA expression level of claudin-3, occludin, and ZO-1; Western blot and immunofluorescence analysis were used for analyzing the expression level and the distribution patterns of ZO-1 protein. RESULTS Pretreatment with baicalin (10.0 μg/mL) improved LPS-stimulated cell viability and repressed IL-6 and TNF-α levels. In addition, pretreatment with baicalin up-regulated mRNA and protein expression levels of ZO-1 and kept the protein intact in IEC-6 cells injured with LPS. CONCLUSIONS Baicalin has the capacity to protect IEC-6 cells and the intercellular tight junctions from LPS-induced injury. The mechanisms may be associated with inhibiting the production of inflammatory cytokines, and up-regulating the mRNA and protein expression of ZO-1.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004751 Enteritis Inflammation of any segment of the SMALL INTESTINE. Enteritides
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D005765 Gastrointestinal Agents Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. Digestants,Gastric Agents,Gastric Drugs,Gastrointestinal Drugs,Agents, Gastric,Agents, Gastrointestinal,Drugs, Gastric,Drugs, Gastrointestinal
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents

Related Publications

Jian Chen, and Ren Zhang, and Jian Wang, and Peng Yu, and Quan Liu, and Dan Zeng, and Houpan Song, and Zaoyuan Kuang
September 2013, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Jian Chen, and Ren Zhang, and Jian Wang, and Peng Yu, and Quan Liu, and Dan Zeng, and Houpan Song, and Zaoyuan Kuang
January 2022, Frontiers in pharmacology,
Jian Chen, and Ren Zhang, and Jian Wang, and Peng Yu, and Quan Liu, and Dan Zeng, and Houpan Song, and Zaoyuan Kuang
January 2014, Journal of immunology research,
Jian Chen, and Ren Zhang, and Jian Wang, and Peng Yu, and Quan Liu, and Dan Zeng, and Houpan Song, and Zaoyuan Kuang
February 2021, Molecules (Basel, Switzerland),
Jian Chen, and Ren Zhang, and Jian Wang, and Peng Yu, and Quan Liu, and Dan Zeng, and Houpan Song, and Zaoyuan Kuang
October 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Jian Chen, and Ren Zhang, and Jian Wang, and Peng Yu, and Quan Liu, and Dan Zeng, and Houpan Song, and Zaoyuan Kuang
May 2009, Annals of the New York Academy of Sciences,
Jian Chen, and Ren Zhang, and Jian Wang, and Peng Yu, and Quan Liu, and Dan Zeng, and Houpan Song, and Zaoyuan Kuang
February 2016, Journal of pharmaceutical sciences,
Jian Chen, and Ren Zhang, and Jian Wang, and Peng Yu, and Quan Liu, and Dan Zeng, and Houpan Song, and Zaoyuan Kuang
April 2016, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Jian Chen, and Ren Zhang, and Jian Wang, and Peng Yu, and Quan Liu, and Dan Zeng, and Houpan Song, and Zaoyuan Kuang
February 2018, The Journal of surgical research,
Jian Chen, and Ren Zhang, and Jian Wang, and Peng Yu, and Quan Liu, and Dan Zeng, and Houpan Song, and Zaoyuan Kuang
February 2012, Inflammation,
Copied contents to your clipboard!